Trial intelligence / Profile preview

Boceprevir therapy and HCV-specific T-cell response study

2011-002911-27Phase 3Completed

Sponsor

Azienda Ospedaliero-Universitaria di Parma

Start

Jul 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1